$ALAB

Astera Labs Stock Rises After Revenue Jumps 154%

Astera Labs (ALAB) reported Q3 revenue of $584.9M, up 154% YoY, beating estimates. Non-GAAP EPS was $1.32 vs. $1.19 expected. Non-GAAP operating margin widened to 44.7%, but gross margin slipped to 72.4%. Q4 guidance: revenue $730M-$750M, non-GAAP EPS $1.62-$1.66. Inventory rose to $200.9M.

Original reporting
Published Nov 4, 2026, 11:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Astera Labs Stock Rises After Revenue Jumps 154% — source image
Decision brief

The 30-second read

$ALABBullishHigh
01

Why it matters

The earnings beat and raised guidance reinforce the company's growth narrative, likely attracting momentum traders.

02

Market read

The surprise earnings and upbeat outlook make ALAB a near‑term buying candidate, especially in the premarket.

03

What to watch

The slip in non‑GAAP gross margin and rising inventory may temper the upside if demand softens.

Relevance 8/10Novelty 8/10Timing: premarket today

Background

Astera Labs (NASDAQ:ALAB) provides high‑performance connectivity solutions for AI data centers. The company has been scaling production of its Scorpio X‑Series switches.

Company-level read

Ticker impact

$ALABBullishHigh confidence
Context

Astera Labs reported record Q4 revenue of $584.9M (+154% YoY) beating estimates and raised Q4 revenue guidance to $730‑$750M.

Expected impact

upward pressure as the market prices in the revenue beat and raised guidance

Evidence & confidence

The company delivered a significant earnings surprise and provided a robust outlook, which typically drives buying interest.

Market effects

Strong results may boost sentiment for AI infrastructure and connectivity chip makers.

U.S. tech sector could see modest uplift in the premarket session.

Limited to investors focused on AI hardware supply chain.

Counterpoint

Higher inventory levels and narrowing gross margins could signal upcoming pressure on profitability.

Key entities

  • Jitendra Mohan

    CEO of Astera Labs, highlighted platform expansion and new design wins.

Related articles

$ALABMedAI 8/10

Astera Labs (ALAB) Q3 2026 Earnings Call Transcript

Astera Labs (ALAB) reported Q3 2026 revenue of $584.9M, up 49% sequentially and 154% YoY. Growth was driven by the Scorpio X-Series, which surpassed P-Series in revenue. The company launched new products, including Aries 7 and Leo 2, and expanded its customer base. Management expects continued growth and increased design wins, with AI infrastructure demand strengthening.

$ALABHighAI 8/10

Northland upgrades Astera Labs stock rating on strong quarter

Northland upgraded Astera Labs (ALAB) to Outperform with a $315 price target, citing strong Q3 results and raised guidance. The Scorpio switch family exceeded $1B annual run rate, driving 98% revenue growth over the last year. Despite a 21% stock drop, ALAB trades above Fair Value. Other analysts lowered price targets due to valuation concerns.

$ALABMedAI 8/10

Needham cuts Astera Labs stock price target on AI sector valuation

Needham reduced its price target for Astera Labs (ALAB) to $300 from $425, citing AI sector valuation pressures, despite raising its estimates. ALAB's stock fell 21% in a week and is deemed overvalued by InvestingPro's Fair Value calculation. The company reported strong Q3 2026 results, with revenue up 98% YoY to $1.2B, and raised guidance. UBS also cut its target to $290 but raised revenue and earnings forecasts through 2028.

$ALABMed

UBS lowers Astera Labs stock price target on valuation concerns

UBS lowered its price target on Astera Labs (ALAB) to $290 from $300, citing valuation concerns and compressed semiconductor sector multiples. The stock has fallen 21% in the past week. UBS raised revenue and earnings estimates for 2026-2028, forecasting $7.82 EPS by 2028. Astera Labs reported strong Q3 2026 results, with revenue up 154% year-over-year and adjusted earnings of $1.32 per share, beating estimates.